Korea United Pharm Inc. (033270.KS) KSC

Currency In KRW

AD

Valuation

Market Cap311.49B
Enterprise Value285.22B
P/E Ratio3.68
PEG Ratio0.03
Price/Sales Ratio0.88
Price/Book Ratio0.58
Enterprise/Revenue0.79
Enterprise/EBITDA3.61

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.26
Operating Margin0.17
AD

Management Effectiveness

Return On Assets0.13
Return On Equity0.17

Income Statement

Revenue288.76B
Revenue/Share18,734.22
Gross Profit175.41B
EBITDA60.47B
Net Income38.31B
Diluted EPS2,614.37

Balance Sheet

Total Cash178.56B
Total Cash/Share11,222.16
Total Debt14.86B
Total Debt/Equity0.03
Current Ratio5.52
Book Value Per Share31,275.64

Price History

52-Week Change-10.12
52-Week High21,800
52-Week Low16,100
Moving Average 50 Days17,814.8
Moving Average 200 Days19,024.7

Statistics

Average Volume28,952
Shares Outstanding14.44M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate610
Trailing Annual Dividend Yield3.37
Payout Ratio0.13
Last Split Factor51:50
Last Split DateJanuary 20, 2014
AD